Development and Validation of a Clinical Nomogram for Predicting Surgery in Newly Diagnosed Crohn's Disease
Journal of Digestive Diseases · 2025
DOI: 10.1111/1751-2980.13357 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Digestive Diseases, 2025. Verfasst von Chao Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China. Hauptthemen laut MEDLINE: Crohn Disease, Nomograms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China, China Crohn's & Colitis Foundation.
Abstract (Originalsprache)
Objectives
To develop a nomogram with easily available parameters to predict the risk of Crohn's disease (CD)‐related bowel resection in patients with newly diagnosed CD.
Methods
We performed a retrospective cohort study by recruiting patients with newly diagnosed CD between 2005 and 2022. The patients were divided into the training and internal test sets in a 7:3 ratio. Adjusted multivariate Cox regression and least absolute shrinkage and selection operator analyses were used for feature selection. A nomogram was developed and evaluated using 10‐fold cross‐validation.
Results
Altogether 490 patients were included, among whom 67 (13.7%) received CD‐related bowel resection during a median follow‐up of 45.2 months. Stricturing or penetrating behavior, perianal involvement, and higher C‐reactive protein (CRP) were independently associated with a higher risk of CD‐related bowel resection, while higher white blood cell (WBC) and lymphocyte levels and hemoglobin levels were protective factors. The nomogram including disease behavior, hemoglobin, CRP, and lymphocyte and WBC counts yielded a C‐statistic of 0.80 (95% confidence interval [CI] 0.74–0.86) in 10‐fold cross‐validation of the training set. Using the internal test set, the robust performance was verified with C‐statistic, calibration slope, and calibration‐in‐the‐large of 0.80 (95% CI 0.70–0.89), 1.10 (95% CI 0.61–1.56), and 0.28 (95% CI −0.17 to 0.67). Decision curve analyses indicated its potential clinical utility.
Conclusion
The nomogram integrating disease behavior and laboratory data might be a promising approach for early risk stratification of CD‐related bowel resection, hence facilitating personalized treatment for newly diagnosed CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.
- Department of Clinical Medicine, Sun Yat-sen University School of Medicine, Guangzhou, Guangdong Province, China.
- Guangxi Hospital Division of The First Affiliated Hospital, Sun Yat-sen University, Nanning, Guangxi Zhuang Autonomous Region, China.
ORCID-Profile: Chao Li, Ri Rong Chen
Förderung
- National Natural Science Foundation of China
- China Crohn's & Colitis Foundation
Zitieren
APA
Li, C., Zhang, X., Zheng, J. Q., Tie, Y. Z., Zeng, Z. R., Chen, M. H., Chen, R. R., & Zhang, S. H. (2025). Development and Validation of a Clinical Nomogram for Predicting Surgery in Newly Diagnosed Crohn's Disease. Journal of Digestive Diseases. https://doi.org/10.1111/1751-2980.13357
Vancouver
Li C, Zhang X, Zheng JQ, Tie YZ, Zeng ZR, Chen MH, et al. Development and Validation of a Clinical Nomogram for Predicting Surgery in Newly Diagnosed Crohn's Disease. Journal of Digestive Diseases. 2025. doi:10.1111/1751-2980.13357
BibTeX
@article{Li2025,
author = {Li, Chao and Zhang, Xi and Zheng, Jie Qi and Tie, Yi Zhe and Zeng, Zhi Rong and Chen, Min Hu and Chen, Ri Rong and Zhang, Sheng Hong},
title = {Development and Validation of a Clinical Nomogram for Predicting Surgery in Newly Diagnosed Crohn's Disease},
journal = {Journal of Digestive Diseases},
year = {2025},
doi = {10.1111/1751-2980.13357}
}
EUVIMED